Fact checked by Jennifer Klump Key Takeaways The American Cancer Society now recommends stool-based tests and a blood test as ...

Time for a rear-ality check. Colorectal cancer rates have been rising among adults younger than 50 since the 1990s, a troubling trend that has perplexed scientists. Because of the increase in cases, ...

Since launching in 2012, more than 50 million Fecal Dx antigen tests have been run worldwide, 2 reflecting strong clinical ...

It’s increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger ...

IDEXX Laboratories (NasdaqGS:IDXX) has expanded its Fecal Dx antigen testing to detect taeniid tapeworm in companion animals.

WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the expansion of its Fecal Dx® antigen testing platform ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

A recent study found that patients who had a positive fecal occult blood test (FOBT) but didn’t follow through with a colonoscopy had a fourfold higher risk for colorectal cancer (CRC) than the ...

A new study found fecal immunochemical testing is more effective than guaiac fecal occult blood testing and is often performed at a lower cost, according to findings published by the Journal of the ...

IDEXX Laboratories, Inc. IDXX recently expanded its Fecal Dx antigen testing platform with the addition of Cystoisospora — a common intestinal parasite that is the source of diarrhea, weight loss and ...